| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0140-6736(79)92202-5 |
| P953 | full work available at URL | https://api.elsevier.com/content/article/PII:S0140673679922025?httpAccept=text/plain |
| https://api.elsevier.com/content/article/PII:S0140673679922025?httpAccept=text/xml | ||
| P698 | PubMed publication ID | 90944 |
| P2093 | author name string | J. Simpson | |
| A. Gordon | |||
| C. M. Yates | |||
| A. F. Maloney | |||
| Y. Allison | |||
| P2860 | cites work | Regional distribution of enzymes associated with neurotransmission by monoamines, acetylcholine and GABA in the human brain | Q39192409 |
| Dendro axonic transmission. I. Evidence from receptor binding of dopaminergic and cholinergic agents | Q39251746 | ||
| Dendro axonic neurotransmission. II. Morphological sites for the synthesis, binding and release of neurotransmitters in dopaminergic dendrites in the substantia nigra and cholinergic dendrites in the neostriatum | Q39262544 | ||
| Neurotransmitter enzyme abnormalities in senile dementia. Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue | Q39835119 | ||
| The natural history of lung cancer: A review based on rates of tumour growth | Q39898571 | ||
| Late deaths after resection for bronchial carcinoma | Q41543954 | ||
| Radiochemical micro assays for the determination of choline acetyltransferase and acetylcholinesterase activities | Q41984049 | ||
| Regional distribution of monoamines and their metabolites in the human brain | Q44581563 | ||
| The relationship between growth rate, labelling index and histological type of human solid tumours | Q45266416 | ||
| Selective loss of central cholinergic neurons in Alzheimer's disease | Q48342983 | ||
| A rapid radiochemical method for the determination of choline acetyltransferase | Q48478137 | ||
| Post-mortem distribution of dopamine and homovanillic acid in human brain, variations related to age, and a review of the literature | Q66895588 | ||
| ??? | Q64880451 | ||
| P433 | issue | 8147 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| dementia | Q83030 | ||
| dopamine | Q170304 | ||
| P304 | page(s) | 851-852 | |
| P577 | publication date | 1979-10-01 | |
| 1979-10-20 | |||
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | Dopamine in Alzheimer's disease and senile dementia | |
| P478 | volume | 2 |
| Q33621285 | A double-blind, placebo controlled trial of high-dose lecithin in Alzheimer's disease |
| Q40264745 | Biochemistry of Alzheimer's dementia |
| Q48713477 | Catecholamines and cholinergic enzymes in pre-senile and senile Alzheimer-type dementia and down's syndrome |
| Q48641408 | Changes of Biogenic Amines and Their Metabolites in Postmortem Brains from Patients with Alzheimer-Type Dementia |
| Q38596419 | Chronic oral physostigmine without lecithin improves memory in Alzheimer's disease |
| Q39173624 | Critical review of clinical trials in senile dementia--II. |
| Q39480484 | Dementia in movement disorders. |
| Q39480888 | Discrepancy between Alzheimer-type neuropathology and dementia in persons with Down's syndrome |
| Q61452627 | Dopamine levels in human tear fluid |
| Q41958103 | Dopaminergic neurotransmitter systems in Alzheimer's disease and in Down's syndrome at middle age. |
| Q34578939 | Effect of tetrahydroaminoacridine on cognition, function and behaviour in Alzheimer's disease. |
| Q53185351 | Expression of monoamine oxidase B activity in astrocytes of senile plaques. |
| Q57317974 | Increased CSF HVA response to arecoline challenge in Alzheimer's disease |
| Q61838423 | Increased response of serum prolactin to metoclopramide in senile dementia of Alzheimer type |
| Q38962796 | Mitochondrial Dysfunction and Synaptic Transmission Failure in Alzheimer's Disease |
| Q33619754 | Monoamine metabolite concentrations in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia |
| Q39552724 | Neurochemical aspects of Alzheimer's disease: involvement of membrane phospholipids |
| Q40089993 | Neurotransmitter deficits in Alzheimer's disease: criteria for significance |
| Q40086658 | Neurotransmitter systems in aging and senile dementia |
| Q49012907 | Reflections on Alzheimer's Disease |
| Q41317848 | Selegiline in treatment of behavioral and cognitive symptoms of Alzheimer disease |
| Q41361767 | The cholinergic hypothesis: a historical overview, current perspective, and future directions |
| Q40091112 | The neurochemistry of Alzheimer's disease and senile dementia |
| Q33755706 | The noradrenergic system in Alzheimer and multi-infarct dementias |
| Q33629702 | The substantia nigra and ventral tegmental area in Alzheimer's disease and Down's syndrome |
| Q53310256 | Treatment of Alzheimer's Disease: A Cautionary Note |
Search more.